Overseed is a French biotech startup operating in the therapeutic cannabis industry. The company combines expertise in genetics, agronomy, natural substance chemistry, and pharmaceuticals to master the production of therapeutic cannabis. Overseed's primary business activities include the production and research of cannabinoids for medical applications.

The company's product offerings include dried cannabis flowers, full-spectrum extracts, and purified active ingredients of pharmaceutical quality. These products are primarily targeted towards laboratories. Overseed's research and experimentation aim to meet the expectations of patients and the health industry. The company ensures the sovereignty of production, proximity of collaborations, and certified quality of cultivated products, directly linked with the expression of medical scientific studies.

Overseed's business model is based on providing R&D services for the production, stabilization, and fine characterization of pharmaceutical-quality cannabinoids for industrial purposes. It is noteworthy that Overseed is the first French player to have obtained an R&D authorization on medical cannabis cultivation.

In terms of revenue generation, Overseed makes money by selling its high-quality cannabis products to laboratories and offering R&D services to other businesses in the industry.

Keywords: Biotech, Therapeutic Cannabis, Cannabinoids, Medical Applications, Dried Cannabis Flowers, Full-Spectrum Extracts, Purified Active Ingredients, Pharmaceutical Quality, Research and Development, Medical Cannabis Cultivation.